Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
about
Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancersHuman marrow stromal cells downsize the stem cell fraction of lung cancers by fibroblast growth factor 10.Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancerAngiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition.A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models.Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice.The ins and outs of fibroblast growth factor receptor signalling.Nestin phosphorylation at threonines 315 and 1299 correlates with proliferation and metastasis of human pancreatic cancer.Cancer stem cells and epithelial-mesenchymal transition: Novel therapeutic targets for cancer.GAGE12 mediates human gastric carcinoma growth and metastasis.Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases.Advances and challenges in targeting FGFR signalling in cancer.Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment.Desmoplasia in pancreatic cancer. Can we fight it?Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.Expression of the FGFR2c mesenchymal splicing variant in human keratinocytes inhibits differentiation and promotes invasion.Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
P2860
Q26998955-D69DAB36-1FBF-432B-99F8-BE5FF5BC04A0Q34056467-94C18B8C-3213-4C2F-8F51-86AEB16CF0A7Q35713603-F14E4EB2-86C3-4B15-BB15-2464B7396B4AQ36729407-D865D5ED-C0E1-4B8D-8046-C26612AD7A80Q36905686-34EC05C3-F5A0-45F8-8BC9-BB340500AEACQ37317641-55EAE030-7410-4334-82F2-DB6D7851946EQ37507462-98D653C8-60A5-4B90-87A4-C5EC8F4C2955Q37605986-632B9626-641A-4971-960F-C7B95EDAE61AQ38208062-5D5A66B5-4446-4D0D-814F-112A4DF6598DQ38724970-C7398BBE-4ADD-41C3-9E65-FE050921DF15Q38924208-AF609958-D150-4064-8422-FB9499F3E6A9Q38945005-2E15A43F-EF47-4754-8A45-EA99B84F86B3Q39090188-DC6C43AA-4C82-434C-85EB-BDFABAA499AEQ39183442-DA623562-95FD-4D3A-B30B-A02D75750ADFQ39282670-4B1C139E-2AA6-4FDD-B765-59CDE3538ECBQ41597479-72591023-B65A-4B80-8C91-49C7D33D89C5Q42198612-9806DAE4-DE9B-4392-9084-4C7872587DD1Q48130149-0896C472-C5BB-4E1A-A645-7AAE7BCCF866Q52564290-279C0FEA-CBA4-47E7-8155-43EC8C24DD03
P2860
Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Enhanced expression of fibrobl ...... tic cancer cell proliferation.
@ast
Enhanced expression of fibrobl ...... tic cancer cell proliferation.
@en
type
label
Enhanced expression of fibrobl ...... tic cancer cell proliferation.
@ast
Enhanced expression of fibrobl ...... tic cancer cell proliferation.
@en
prefLabel
Enhanced expression of fibrobl ...... tic cancer cell proliferation.
@ast
Enhanced expression of fibrobl ...... tic cancer cell proliferation.
@en
P2093
P2860
P1476
Enhanced expression of fibrobl ...... tic cancer cell proliferation.
@en
P2093
Eiji Uchida
Murray Korc
Tetsushi Yamamoto
Toshiyuki Ishiwata
Yoko Matsuda
Zenya Naito
P2860
P304
P356
10.1016/J.AJPATH.2012.01.020
P407
P577
2012-03-19T00:00:00Z